GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Days Inventory

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Days Inventory : 137.69 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Tianjin Pharmaceutical Da Ren Tang Group's Average Total Inventories for the three months ended in Mar. 2024 was ¥1,525 Mil. Tianjin Pharmaceutical Da Ren Tang Group's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥1,011 Mil. Hence, Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory for the three months ended in Mar. 2024 was 137.69.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory or its related term are showing as below:

SHSE:600329' s Days Inventory Range Over the Past 10 Years
Min: 61.99   Med: 113.79   Max: 139.66
Current: 127.29

During the past 13 years, Tianjin Pharmaceutical Da Ren Tang Group's highest Days Inventory was 139.66. The lowest was 61.99. And the median was 113.79.

SHSE:600329's Days Inventory is ranked better than
63.07% of 972 companies
in the Drug Manufacturers industry
Industry Median: 158.805 vs SHSE:600329: 127.29

Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory increased from Mar. 2023 (119.62) to Mar. 2024 (137.69). It might indicate that Tianjin Pharmaceutical Da Ren Tang Group's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tianjin Pharmaceutical Da Ren Tang Group's Inventory Turnover for the three months ended in Mar. 2024 was 0.66.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tianjin Pharmaceutical Da Ren Tang Group's Inventory-to-Revenue for the three months ended in Mar. 2024 was 0.73.


Tianjin Pharmaceutical Da Ren Tang Group Days Inventory Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Days Inventory Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 131.81 139.66 132.48 108.81 118.76

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 119.62 134.08 149.70 104.88 137.69

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory falls into.



Tianjin Pharmaceutical Da Ren Tang Group Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (1429.452 + 1566.518) / 2 ) / 4604.084*365
=1497.985 / 4604.084*365
=118.76

Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

Days Inventory (Q: Mar. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (1566.518 + 1483.364) / 2 ) / 1010.616*365 / 4
=1524.941 / 1010.616*365 / 4
=137.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Pharmaceutical Da Ren Tang Group  (SHSE:600329) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tianjin Pharmaceutical Da Ren Tang Group's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tianjin Pharmaceutical Da Ren Tang Group's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Tianjin Pharmaceutical Da Ren Tang Group Days Inventory Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines